-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Breast cancer is the most common cancer worldwide and the main cause of death from cancer in women
.
With a better understanding of the biological behavior of tumor, screening of innovative technologies and integrated multidisciplinary treatment strategy development, more breast cancer at an early stage diagnosis out
Breast cancer is the most common cancer worldwide and the main cause of death from cancer in women
The study retrospectively analyzed early breast cancer patients who underwent surgery in Ruijin Hospital affiliated to Shanghai Jiaotong University from January 2009 to March 2018
.
LRR is defined as recurrence in the ipsilateral breast (IBTR), chest wall, or regional lymph nodes without complicated distant metastasis (DM)
The study retrospectively analyzed early breast cancer patients who underwent surgery in Ruijin Hospital affiliated to Shanghai Jiaotong University from January 2009 to March 2018
A total of 5202 patients were included in the study
After a median follow-up of 47.
Multivariate analysis showed tumor size (p<0.
Multivariate analysis of recurrence related factors
Multivariate analysis of recurrence related factorsForty (46.
0%) of 87 LRR patients underwent further salvage surgery
.
Multivariate analysis showed that the size of the primary tumor (p = 0.
Forty (46.
The 5-year OS rates of LRR patients, DM patients, and patients without recurrence were 80.
Comparison of prognosis
Comparison of prognosisThe median follow-up time after recurrence was 21.
3 months (range: 1.
0-77.
5), with 30 deaths
.
The PR-OS of patients with LRR as the first event was significantly better than that of DM patients (3-year PR-OS 75.
The median follow-up time after recurrence was 21.
Comparison of prognosis after recurrence
Comparison of prognosis after recurrenceMultivariate analysis showed that ER positive (HR = 0.
33, 95% CI 0.
12 0.
91, p = 0.
033) and LRR salvage surgery (HR = 0.
11, 95% CI 0.
02 0.
93, p = 0.
043) were independent of the improvement of PR-OS in LRR patients Related
.
33, 95% CI 0.
12 0.
91, p = 0.
033) and LRR salvage surgery (HR = 0.
11, 95% CI 0.
02 0.
93, p = 0.
043) were independent of the improvement of PR-OS in LRR patients Related
.
In summary, studies have shown that in modern breast cancer treatments, the LRR rate is relatively low
.
Tumor size and lymph node status are related to the risk of LRR, and salvage surgery for selected LRR patients has achieved good results
.
.
Tumor size and lymph node status are related to the risk of LRR, and salvage surgery for selected LRR patients has achieved good results
.
Studies have shown that in modern breast cancer treatments, the LRR rate is relatively low
.
Tumor size and lymph node status are related to the risk of LRR, and salvage surgery for selected LRR patients has achieved good results
.
Studies have shown that in modern breast cancer treatments, the LRR rate is relatively low
.
Tumor size and lymph node status are related to the risk of LRR, and salvage surgery for selected LRR patients has achieved good results
.
Original source:
Original source:Huang J, Tong Y, Chen X and Shen K (2021) Prognostic Factors and Surgery for Breast Cancer Patients With Locoregional Recurrence: An Analysis of 5,202 Consecutive Patients.
Front.
Oncol.
11:763119.
doi: 10.
3389/fonc.
2021.
763119
Front.
Oncol.
11:763119.
doi: 10.
3389/fonc.
2021.
763119 here message